Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,993.74 -1,476.12 (-2.29%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Nuvation Bio Inc. (NUVB)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 661.23M |
| Enterprise value | 54.03M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.09 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.37 |
| 52-week change 3 | 66.46% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 4.1600 |
| 52-week low 3 | 0.9500 |
| 50-day moving average 3 | 2.5482 |
| 200-day moving average 3 | 1.7554 |
Share statistics
| Avg vol (3-month) 3 | 1.33M |
| Avg vol (10-day) 3 | 1.04M |
| Shares outstanding 5 | 245.73M |
| Implied shares outstanding 6 | 246.73M |
| Float 8 | 135.84M |
| % held by insiders 1 | 24.53% |
| % held by institutions 1 | 54.85% |
| Shares short (15 Apr 2024) 4 | 3.19M |
| Short ratio (15 Apr 2024) 4 | 1.31 |
| Short % of float (15 Apr 2024) 4 | 2.18% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.29% |
| Shares short (prior month 15 Mar 2024) 4 | 2.82M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -9.65% |
| Return on equity (ttm) | -12.03% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -99.6M |
| Net income avi to common (ttm) | -75.8M |
| Diluted EPS (ttm) | -0.3500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 611.21M |
| Total cash per share (mrq) | 2.79 |
| Total debt (mrq) | 4.01M |
| Total debt/equity (mrq) | 0.66% |
| Current ratio (mrq) | 44.11 |
| Book value per share (mrq) | 2.76 |
Cash flow statement
| Operating cash flow (ttm) | -68M |
| Levered free cash flow (ttm) | -41.59M |
© 2024 Yahoo. All rights reserved.